SCHEMBL25079571

SCHEMBL25079571

O=C1CCN(c2cccc(OCC(=O)N3CCNCC3)c2)C(=O)N1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TPSAB1 Q15661 1/20 0.51
▸ TPSD1 Q9BZJ3 1/20 0.51
▸ TPSG1 Q9NRR2 1/20 0.51
▸ DDB1 Q16531 6/20 0.51
▸ CRBN Q96SW2 6/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ GAA P10253 2/20 0.45
▸ RECQL P46063 1/20 0.44
▸ FKBP1A P62942 1/20 0.44
▸ ENPP2 Q13822 3/20 0.43
▸ MAPT P10636 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ NPC1 O15118 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ CPT2 P23786 1/20 0.41
▸ CPT1A P50416 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25079332 0.87 TPSAB1 (0.61) TPSAB1TPSD1TPSG1DDB1CRBN
SCHEMBL24530703 0.85 DDB1 (0.50) DDB1CRBNL3MBTL1MEN1KMT2A
SCHEMBL29607604 0.83 DDB1 (0.57) DDB1CRBNMEN1KMT2AMAPT
SCHEMBL23120540 0.83 DDB1 (0.57) DDB1CRBNMEN1KMT2AMAPT
SCHEMBL25079570 0.83 DDB1 (0.52) DDB1CRBNMEN1KMT2AGAA
SCHEMBL30257613 0.83 DDB1 (0.52) DDB1CRBNMEN1KMT2AGAA
SCHEMBL31255633 0.82 DDB1 (0.53) TPSAB1TPSD1TPSG1DDB1CRBN
Hydrochloric Acid SCHEMBL31255623 0.81 DDB1 (0.52) TPSAB1TPSD1TPSG1DDB1CRBN
SCHEMBL23120512 0.81 HSD17B10 (0.50) DDB1CRBNKMT2AGAAHPGD
SCHEMBL29606381 0.81 HSD17B10 (0.50) DDB1CRBNKMT2AGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023023531-A1 ESTROGEN RECEPTOR DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2023-02-23 — — WO disclosed
Send feedback